Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis
Abstract Background Most previous studies compared the risk for non-melanoma skin cancer (NMSC) in biologic-treated common inflammatory diseases with the general population. Whether the increased NMSC risk is caused by the disease itself, the biologics, or both remains unknown. Methods We systematic...
Guardado en:
Autores principales: | Ruolin Liu, Qianyi Wan, Rui Zhao, Haitao Xiao, Ying Cen, Xuewen Xu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/22b616d7155c448da005b4c2b2a7582e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Advances in understanding N-glycosylation structure, function, and regulation in health and disease
por: Sally Esmail, et al.
Publicado: (2021) -
Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature
por: Turse EP, et al.
Publicado: (2018) -
Correlation of CCL8 expression with immune cell infiltration of skin cutaneous melanoma: potential as a prognostic indicator and therapeutic pathway
por: Peipei Yang, et al.
Publicado: (2021) -
Anticancer effects of mifepristone on human uveal melanoma cells
por: Prisca Bustamante Alvarez, et al.
Publicado: (2021) -
ROS Pleiotropy in Melanoma and Local Therapy with Physical Modalities
por: Sanjeev Kumar Sagwal, et al.
Publicado: (2021)